Seuss+ has spent over 13 years guiding biotech sponsors through vendor complexity and clinical execution with hands‑on support that accelerates decision‑making and reinforces internal leadership.

We embed the structure needed to connect strategy with delivery, so sponsors can stay milestone-focused, investor-aligned, and audit-ready.

Founded by Kieran Engels and Sabine Hutchison, Seuss+ was built to prevent the operational failures that derail even the strongest science. Issues that rarely stem from the asset itself, but from misaligned vendors, unclear ownership, and oversight that comes too late. We focus on building governance frameworks that create real-time visibility and control across clinical execution.

Helping sponsors manage risk where it matters most: in the execution that sustains both scientific progress and investor confidence.

We don’t just support trials. We protect their value.